CIK 0001743881
- Large accelerated filer
BridgeBio Pharma, Inc.
Sign in to watch- Ticker
- BBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 650-391-9740
- Business address
- 3160 PORTER DR., SUITE 250, PALO ALTO, CA, 94304
- Former names
- BridgeBio Pharma LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,676,804
- in 3 filings, $1.7M under 10b5-1 plans
Net −$1,676,804. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-06-17 | Lo Andrew Director | Grant or award · Stock Option (right to buy) | +38,895 | 38,895 | ||
| 2021-06-17 | MOMTAZEE JAMES C Director | Grant or award · Stock Option (right to buy) | +38,895 | 38,895 | ||
| 2021-06-17 | HOMCY CHARLES J Director | Grant or award · Stock Option (right to buy) | +38,895 | 38,895 | ||
| 2021-06-17 | DANIELS RONALD J Director | Grant or award · Stock Option (right to buy) | +38,895 | 38,895 | ||
| 2021-06-17 | SAUNDERS BRENT L Director | Grant or award · Stock Option (right to buy) | +38,895 | 38,895 | ||
| 2021-06-17 | Cook Jennifer E. Director | Grant or award · Stock Option (right to buy) | +38,895 | 38,895 | ||
| 2021-06-17 | SCHELLER RICHARD H Chairman of R&D | Grant or award · Stock Option (right to buy) | +38,895 | 38,895 | ||
| 2021-06-17 | Scott Randal W. Director | Grant or award · Stock Option (right to buy) | +38,895 | 38,895 | ||
| 2021-06-17 | AGUIAR ERIC Director | Grant or award · Stock Option (right to buy) | +38,895 | 38,895 | ||
| 2021-05-16 | Kumar Neil CEO and President | Option exercise | +7,524 | 4,718,949 | ||
| 2021-05-16 | Kumar Neil CEO and President | Shares withheld for taxes | −3,731 | $53.66 | $200K | 4,715,218 |
| 2021-05-16 | Kumar Neil CEO and President | Option exercise · Restricted Stock Units | −5,130 | 61,552 | ||
| 2021-05-16 | Kumar Neil CEO and President | Option exercise · Restricted Stock Units | −2,394 | 35,912 | ||
| 2021-05-16 | STEPHENSON BRIAN C See Remarks | Option exercise | +2,488 | 302,531 | ||
| 2021-05-16 | STEPHENSON BRIAN C See Remarks | Shares withheld for taxes | −862 | $53.66 | $46K | 301,669 |
| 2021-05-16 | STEPHENSON BRIAN C See Remarks | Option exercise · Restricted Stock Units | −1,710 | 20,517 | ||
| 2021-05-16 | STEPHENSON BRIAN C See Remarks | Option exercise · Restricted Stock Units | −778 | 11,671 | ||
| 2021-03-01 | HOMCY CHARLES J Director | Grant or award | +1,521 | 1,205,288 | ||
| 2021-03-01 | HOMCY CHARLES J Director | Shares withheld for taxes | −524 | $71.91 | $38K | 1,204,764 |
| 2021-02-17 | STEPHENSON BRIAN C See Remarks | Purchase | +8,000 | $62.50 | $500K | 300,043 |
Page 39 of 44 · 868 trades